Please log in to see the full text of this API!
Prazosin
-
ATC:
C02CA01
-
Use:
Lorem
Lorem
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:383.41 g/mol
-
CAS-RN:19216-56-9
-
InChI Key:IENZQIKPVFGBNW-UHFFFAOYSA-N
-
InChI:InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)
-
EINECS:242-885-8
-
LD50:>400 mg/kg (M, i.v.); >4 g/kg (M, p.o.)
Derivatives
monohydrochloride
-
Use:
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:419.87 g/mol
-
CAS-RN:19237-84-4
-
EINECS:242-903-4
-
LD50:92 mg/kg (M, i.v.); 5 g/kg (M, p.o.);
73 mg/kg (R, i.v.); 1950 mg/kg (R, p.o.);
>700 mg/kg (dog, p.o.)
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
23680-84-4 |
C10H10ClN3O2 |
4-amino-2-chloro-6,7-dimethoxyquinazoline |
4-Quinazolinamine, 2-chloro-6,7-dimethoxy- |
5653-40-7 |
C9H11NO4 |
2-amino-4,5-dimethoxybenzoic acid |
Benzoic acid, 2-amino-4,5-dimethoxy- |
27631-29-4 |
C10H8Cl2N2O2 |
2,4-dichloro-6,7-dimethoxyquinazoline |
Quinazoline, 2,4-dichloro-6,7-dimethoxy- |
28888-44-0 |
C10H10N2O4 |
2,4-dihydroxy-6,7-dimethoxyquinazoline |
2,4(1H,3H)-Quinazolinedione, 6,7-dimethoxy- |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
D |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
F |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
GB |
Lorem |
Lorem
|
|
I |
Lorem |
Lorem
,1978 |
|
J |
Lorem |
Lorem
|
|
USA |
Lorem |
Lorem
|
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumyeirmodtemporinviduntutlaboreetdoloremagnaaliquyamerat,sed
References
-
- US 9 999 999 (Pfizer; 12.5.1970; appl. 13.12.1967; prior. 6.8.1965, 7.6.1966).
- US 9 999 999 (Pfizer; 18.1.1972; prior. 6.8.1965, 7.6.1966, 13.12.1967).
- US 9 999 999 (Pfizer; 16.5.1972; prior. 6.8.1965, 13.12.1967, 12.5.1970).
- DAS 9 999 999 (Pfizer; appl. 2.7.1966; USA-prior. 6.7.1965, 7.6.1966).
-
alternative synthesis:
- US 9 999 999 (Pfizer; 27.1.1976; prior. 5.12.1973).
- DOS 9 999 999 (Pfizer; appl. 4.12.1974; USA-prior. 5.12.1973).
- DOS 9 999 999 (Pfizer; appl. 11.7.1977; USA-prior. 6.8.1976).
- US 9 999 999 (Pfizer; 13.12.1977; appl. 20.9.1976).
- US 9 999 999 (Bristol-Myers; 6.2.1979; prior. 30.9.1977).
- BE 999 999 (Fermion; appl. 14.12.1977; SF-prior. 15.12.1976).
- BE 999 999 (Fermion; appl. 14.12.1977; SF-prior. 15.12.1976).
-
α-form:
- US 9 999 999 (Pfizer; 30.5.1978; appl. 1.3.1976).
- DAS 9 999 999 (Pfizer; appl. 25.2.1977; USA-prior. 1.3.1976).
-
anhydrous crystalline form:
- DE 9 999 999 (Orion; appl. 9.8.1984; FL-prior. 25.6.1984).
- US 9 999 999 (Heumann Pharma; 28.3.1989; appl. 3.3.1987; EP-prior. 21.3.1986).
-
metabolites of prazosin:
- Althuis, T.H. et al.: J. Med. Chem. (JMCMAR) 20, 999 (1976).